Literature DB >> 26615128

Functional Crosstalk Between WNT Signaling and Tyrosine Kinase Signaling in Cancer.

Jaimie N Anastas1.   

Abstract

Extensive molecular characterization of tumors has revealed that the activity of multiple signaling pathways is often simultaneously dampened or enhanced in cancer cells. Aberrant WNT signaling and tyrosine kinase signaling are two pathways that are frequently up- or downregulated in cancer. Although signaling pathways regulated by WNTs, tyrosine kinases, and other factors are often conceptualized as independent entities, the biological reality is likely much more complex. Understanding the mechanisms of crosstalk between multiple signal transduction networks is a key challenge for cancer researchers. The overall goals of this review are to describe mechanisms of crosstalk between WNT and tyrosine kinase pathways in cancer and to discuss how understanding intersections between WNT and tyrosine kinase signaling networks might be exploited to improve current therapies.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26615128     DOI: 10.1053/j.seminoncol.2015.09.020

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  9 in total

Review 1.  Intercalated discs: cellular adhesion and signaling in heart health and diseases.

Authors:  Guangze Zhao; Ye Qiu; Huifang M Zhang; Decheng Yang
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

2.  Convergence of Wnt, growth factor, and heterotrimeric G protein signals on the guanine nucleotide exchange factor Daple.

Authors:  Nicolas Aznar; Jason Ear; Ying Dunkel; Nina Sun; Kendall Satterfield; Fang He; Nicholas A Kalogriopoulos; Inmaculada Lopez-Sanchez; Majid Ghassemian; Debashis Sahoo; Irina Kufareva; Pradipta Ghosh
Journal:  Sci Signal       Date:  2018-02-27       Impact factor: 8.192

Review 3.  Beyond cell-cell adhesion: Plakoglobin and the regulation of tumorigenesis and metastasis.

Authors:  Zackie Aktary; Mahsa Alaee; Manijeh Pasdar
Journal:  Oncotarget       Date:  2017-05-09

4.  Knockdown of CCNO decreases the tumorigenicity of gastric cancer by inducing apoptosis.

Authors:  Lan Li; Yu Cao; Hourong Zhou; Yu Li; Bing He; Xia Zhou; Zhao Nie; Li Liang; Ying Liu; Limin Ye
Journal:  Onco Targets Ther       Date:  2018-10-26       Impact factor: 4.147

5.  Differential effects, on oncogenic pathway signalling, by derivatives of the HNF4 α inhibitor BI6015.

Authors:  Jin-Hee Kim; Hyo Jin Eom; GyuTae Lim; Sungjin Park; Jinhyuk Lee; Seungyoon Nam; Yon Hui Kim; Jin-Hyun Jeong
Journal:  Br J Cancer       Date:  2019-02-22       Impact factor: 7.640

6.  Ryk modulates the niche activity of mesenchymal stromal cells by fine-tuning canonical Wnt signaling.

Authors:  Seon-Yeong Jeong; Jungmook Lyu; Jin-A Kim; Il-Hoan Oh
Journal:  Exp Mol Med       Date:  2020-07-28       Impact factor: 8.718

7.  In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth.

Authors:  Michael Bordonaro; Senji Shirasawa; Darina L Lazarova
Journal:  Cancers (Basel)       Date:  2016-05-14       Impact factor: 6.639

8.  Novel multiple tyrosine kinase inhibitor ponatinib inhibits bFGF-activated signaling in neuroblastoma cells and suppresses neuroblastoma growth in vivo.

Authors:  Haoyu Li; Yongfeng Wang; Zhenghu Chen; Jiaxiong Lu; Jessie Pan; Yang Yu; Yanling Zhao; Huiyuan Zhang; Ting Hu; Qing Liu; Jianhua Yang
Journal:  Oncotarget       Date:  2017-01-24

9.  An integrative pharmacogenomics analysis identifies therapeutic targets in KRAS-mutant lung cancer.

Authors:  Haiyun Wang; Qi Lv; Yue Xu; Zhaoqing Cai; Jie Zheng; Xiaojie Cheng; Yao Dai; Pasi A Jänne; Chiara Ambrogio; Jens Köhler
Journal:  EBioMedicine       Date:  2019-10-23       Impact factor: 8.143

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.